|
2024
|
Invention
|
Bicyclic and monocyclic trpa1 inhibitors. A compound of Formula I or II or a pharmaceutically acc... |
|
|
Invention
|
Bicyclic imide compounds as trpa1 inhibitors. A compound of Formula (I) or a pharmaceutically acc... |
|
2023
|
Invention
|
Pyridone compounds as trpa1 inhibitors. A compound of Formula (I) or a pharmaceutically acceptabl... |
|
|
Invention
|
Pyridazinone compounds as trpa1 inhibitors.
A compound of Formula (I) or a pharmaceutically acce... |
|
|
Invention
|
N3-substituted uracil compounds as trpa1 inhibitors.
A compound of Formula (I) or a pharmaceutic... |
|
|
Invention
|
N3-substituted uracil compounds as trpa1 inhibitors. A compound of Formula (I) or a pharmaceutica... |
|
|
Invention
|
Pyridazinone compounds as trpa1 inhibitors. A compound of Formula (I) or a pharmaceutically accep... |
|
2022
|
Invention
|
Shp2 phosphatase inhibitors and methods of use thereof. The present disclosure relates to novel c... |
|
|
Invention
|
Joint generation of a molecular graph and three-dimensional geometry.
A machine-learning approac... |
|
|
Invention
|
Joint generation of a molecular graph and three-dimensional geometry. A machine-learning approach... |
|
|
Invention
|
Pi3k-alpha inhibitors and methods of use thereof.
The present disclosure relates to novel compou... |
|
|
Invention
|
Pi3k-alpha inhibitors and methods of use thereof. The present disclosure relates to novel compoun... |
|
|
Invention
|
Spiroindolinone compounds as kv1.3 potassium shaker channel blockers.
A compound of Formula (I) ... |
|
|
Invention
|
Spiroindolinone compounds as kv1.3 potassium shaker channel blockers. A compound of Formula (I) o... |
|
|
Invention
|
Aryl heterocyclic compounds as kv1.3 potassium shaker channel blockers.
A compound of Formula I
... |
|
|
Invention
|
Aryl heterocyclic compounds as kv1.3 potassium shaker channel blockers. A compound of Formula (I)... |
|
|
Invention
|
Multibody simulation.
Improvements in a molecular-dynamic simulator provide ways to save energy ... |
|
|
Invention
|
Multibody simulation. Improvements in a molecular-dynamic simulator provide ways to save energy d... |
|
2021
|
Invention
|
Src inhibitors and uses thereof.
The present invention relates to compounds and methods useful f... |
|
|
Invention
|
Src inhibitors and uses thereof. The present invention relates to compounds and methods useful fo... |
|
|
Invention
|
Lactam compounds as kv1.3 potassium shaker channel blockers.
A compound of Formula (I), or a pha... |
|
|
Invention
|
Lactam compounds as kv1.3 potassium shaker channel blockers. A compound of Formula (I), or a phar... |
|
|
Invention
|
Pi3k.alpha. inhibitors and methods of use thereof. The present disclosure relates to novel compou... |
|
|
Invention
|
Pi3k-α inhibitors and methods of use thereof. The present disclosure relates to novel compounds a... |
|
2020
|
Invention
|
Arylmethylene aromatic compounds as kv1.3 potassium shaker channel blockers.
A compound of Formu... |
|
|
Invention
|
Aryl heterobicyclic compounds as kv1.3 potassium shaker channel blockers.
A compound of Formula ... |
|
|
Invention
|
Aryl heterocyclic compounds as kv1.3 potassium shaker channel blockers.
A compound of Formula (I... |
|
|
Invention
|
Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers.
A compound of F... |
|
|
Invention
|
Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers. A compound of Fo... |
|
|
Invention
|
Aryl heterobicyclic compounds as kv1.3 potassium shaker channel blockers. A compound of Formula (... |
|
|
Invention
|
Arylmethylene aromatic compounds as kv1.3 potassium shaker channel blockers. A compound of Formul... |
|
|
Invention
|
Molecular graph generation from structural features using an artificial neural network. Discoveri... |
|
|
Invention
|
Fgfr inhibitors and methods of use thereof.
The present disclosure relates to novel compounds an... |
|
|
Invention
|
Heterocyclic compounds and their use in the treatment of amyloid-related diseases.
A compound of... |
|
2019
|
Invention
|
Shp2 phosphatase inhibitors and methods of use thereof.
The present disclosure relates to novel ... |
